Literature DB >> 10949996

Generation of an immortal differentiated lung type-II epithelial cell line from the adult H-2K(b)tsA58 transgenic mouse.

D E deMello1, S Mahmoud, P J Padfield, J W Hoffmann.   

Abstract

This paper describes a new fully differentiated Type-II alveolar epithelial cell line designated T7, derived from transgenic H-2K(b)-tsA58 mice, capable of being passaged as an immortalized cloned cell line in culture. H-2K(b)-tsA58 mice harbor a temperature-sensitive (ts) mutant of the simian virus 40 (SV40) large tumor antigen (T antigen) under the control of the gamma-interferon (INF)-inducible mouse major histocompatibility complex H-2Kb promoter. When cultured under permissive conditions (33 degrees C and in the presence of gamma-INF) cells isolated from H-2Kb-tsA58 mice express the large T antigen, which drives the cells to proliferate. However, upon withdrawal of the gamma-INF and transfer of the cells to a higher temperature (39 degrees C), T antigen expression is turned off, the cells stop proliferating and differentiate. The T7 cell line is a clonal cell line originally derived from a Type-II cell-rich fraction isolated from lungs of H-2Kb-tsA58 mice. The T7 cells form confluent monolayers, and have a polarized epithelial cell morphology with tight junctions and apical microvilli. In addition, the T7 cells have distinct cytoplasmic lamellar bodies, which become more numerous and pronounced when the cells are grown under nonpermissive conditions. The T7 cells synthesize and secrete phosphatidylcholine and the three surfactant proteins, SP-A, SP-B, and SP-C. The T7 cell line is unique in that it is the first non-tumor-derived Type-II cell line capable of synthesizing and secreting the major components of surfactant. Based on the criteria studied, the T7 cell line is phenotypically very similar to normal Type-II cells. The T7 cell line, therefore, should prove a valuable experimental system to advance the study of the cell biology/physiology of surfactant metabolism and secretion as well as serve as a model for other studies of Type-II cell physiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949996      PMCID: PMC7101677          DOI: 10.1290/1071-2690(2000)036<0374:GOAIDL>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  44 in total

1.  A rat alveolar type II cell line developed by adenovirus 12SE1A gene transfer.

Authors:  M P Steele; R A Levine; M Joyce-Brady; J S Brody
Journal:  Am J Respir Cell Mol Biol       Date:  1992-01       Impact factor: 6.914

2.  A monoclonal antibody to the 15,000 dalton protein associated with porcine pulmonary surfactant.

Authors:  Y Suzuki; K Kogishi; Y Fujita; T Kina; S Nishikawa
Journal:  Exp Lung Res       Date:  1986       Impact factor: 2.459

3.  Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA.

Authors:  K Tokunaga; H Taniguchi; K Yoda; M Shimizu; S Sakiyama
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

4.  Isolation of nonciliated bronchiolar epithelial (Clara) cells and alveolar type II cells from mouse lungs.

Authors:  T E Massey; B A Geddes; P G Forkert
Journal:  Can J Physiol Pharmacol       Date:  1987-12       Impact factor: 2.273

5.  Constitutive expression of growth-related mRNAs in proliferating and nonproliferating lung epithelial cells in primary culture: evidence for growth-dependent translational control.

Authors:  A Clement; J Campisi; S R Farmer; J S Brody
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line.

Authors:  M A O'Reilly; A F Gazdar; J C Clark; T J Pilot-Matias; S E Wert; W M Hull; J A Whitsett
Journal:  Am J Physiol       Date:  1989-12

7.  Stimulation of lung surfactant secretion by endothelin-1 from rat alveolar type II cells.

Authors:  N Sen; M M Grunstein; A Chander
Journal:  Am J Physiol       Date:  1994-03

8.  Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency.

Authors:  D E deMello; L M Nogee; S Heyman; H F Krous; M Hussain; T A Merritt; W Hsueh; J E Haas; K Heidelberger; R Schumacher
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

9.  Localization, synthesis, and processing of surfactant protein SP-C in rat lung analyzed by epitope-specific antipeptide antibodies.

Authors:  M F Beers; C Y Kim; C Dodia; A B Fisher
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

10.  Glucocorticoid enhances pulmonary surfactant protein B gene transcription.

Authors:  M A O'Reilly; J C Clark; J A Whitsett
Journal:  Am J Physiol       Date:  1991-02
View more
  8 in total

1.  C22-bronchial and T7-alveolar epithelial cell lines of the immortomouse are excellent murine cell culture model systems to study pulmonary peroxisome biology and metabolism.

Authors:  Srikanth Karnati; Saranya Palaniswamy; Mohammad Rashedul Alam; Gani Oruqaj; Cordula Stamme; Eveline Baumgart-Vogt
Journal:  Histochem Cell Biol       Date:  2015-12-21       Impact factor: 4.304

2.  Cholera toxin induces a shift from inactive to active cyclooxygenase 2 in alveolar macrophages activated by Mycobacterium bovis BCG.

Authors:  Mari Kogiso; Tsutomu Shinohara; C Kathleen Dorey; Yoshimi Shibata
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

3.  Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models.

Authors:  Masaji Okada; Yuji Takemoto; Yoshinobu Okuno; Satomi Hashimoto; Yukari Fukunaga; Takao Tanaka; Yoko Kita; Sechiko Kuwayama; Yumiko Muraki; Noriko Kanamaru; Hiroko Takai; Chika Okada; Yayoi Sakaguchi; Izumi Furukawa; Kyoko Yamada; Miwa Izumiya; Shigeto Yoshida; Makoto Matsumoto; Tetsuo Kase; J S M Peiris; Daphne E DeMello; Pei-Jer Chen; Naoki Yamamoto; Yoshiyuki Yoshinaka; Tatsuji Nomura; Isao Ishida; Shigeru Morikawa; Masato Tashiro; Mitsunori Sakatani
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Generation and characterization of a conditionally immortalized lung clara cell line from the H-2Kb-tsA58 transgenic mouse.

Authors:  Daphne E Demello; Sohir Mahmoud; Jan Ryerse; Joseph W Hoffmann
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-03       Impact factor: 2.416

5.  The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: communication between innate and adaptive immune systems.

Authors:  Olga D Chuquimia; Dagbjort H Petursdottir; Muhammad J Rahman; Katharina Hartl; Mahavir Singh; Carmen Fernández
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

6.  Functional analysis of an arthritogenic synovial fibroblast.

Authors:  Vassilis Aidinis; David Plows; Sylva Haralambous; Maria Armaka; Petros Papadopoulos; Maria Zambia Kanaki; Dirk Koczan; Hans Juergen Thiesen; George Kollias
Journal:  Arthritis Res Ther       Date:  2003-03-14       Impact factor: 5.156

7.  Lipopolysaccharide and lipoteichoic acid enhance serum amyloid A3 mRNA expression in murine alveolar epithelial cells.

Authors:  Ami Iwata; Kaori Shimizu; Haruka Kawasaki; Ayaka Okada; Yasuo Inoshima
Journal:  J Vet Med Sci       Date:  2019-08-06       Impact factor: 1.267

8.  The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice.

Authors:  Masaji Okada; Yuji Takemoto; Yoshinobu Okuno; Satomi Hashimoto; Shigeto Yoshida; Yukari Fukunaga; Takao Tanaka; Yoko Kita; Sachiko Kuwayama; Yumiko Muraki; Noriko Kanamaru; Hiroko Takai; Chika Okada; Yayoi Sakaguchi; Izumi Furukawa; Kyoko Yamada; Makoto Matsumoto; Tetsuo Kase; Daphne E Demello; J S M Peiris; Pei-Jer Chen; Naoki Yamamoto; Yoshiyuki Yoshinaka; Tatsuji Nomura; Isao Ishida; Shigeru Morikawa; Masato Tashiro; Mitsunori Sakatani
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.